The pharmacological treatment of urinary incontinence.
Andersson
K E
KE
The Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden. Karl-Erik.Andersson@klinfarm.lu.se
Appell
R
R
Cardozo
L D
LD
Chapple
C
C
Drutz
H P
HP
Finkbeiner
A E
AE
Haab
F
F
Vela Navarrete
R
R
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D006728:Hormones; D007473:Ion Channels; D018727:Muscarinic Antagonists